Antimicrobial resistance of Shiga toxin (verotoxin)-producing Escherichia coli O157:H7 and non-O157 strains isolated from humans, cattle, sheep and food in Spain

Bettelheim, 2003, Antibiotic resistance among verocytotoxigenic Escherichia coli (STEC) and non-STEC isolated from domestic animals and humans, J. Med. Microbiol., 52, 155, 10.1099/jmm.0.04903-0

Beutin, 1998, Human infections with Shiga toxin-producing Escherichia coli other than serogroup O157 in Germany, Emerg. Infect. Dis., 4, 635, 10.3201/eid0404.980415

Beutin, 2002, Characteristics and association with disease of two major subclones of Shiga toxin (verocytotoxin)-producing strains of Escherichia coli (STEC) O157 that are present among isolates from patients in Germany, Diag. Microbiol. Infect. Dis., 44, 337, 10.1016/S0732-8893(02)00474-1

Beutin, 2004, Characterization of Shiga toxin-producing Escherichia coli strains isolated from human patients in Germany over a 3-year period, J. Clin. Microbiol., 42, 1099, 10.1128/JCM.42.3.1099-1108.2004

Blanco, 1993

Blanco, 2001, Epidemiology of verocytotoxigenic Escherichia coli (VTEC) in ruminants, 113

Blanco, 2003, Verotoxin-producing Escherichia coli in Spain: Prevalence, serotypes, and virulence genes of O157:H7 and non-O157 STEC in ruminants, raw beef products, and humans, Exp. Biol. Med., 228, 345, 10.1177/153537020322800403

Blanco, 1997, Prevalence of bacterial resistance to quinolones and other antimicrobials among avian Escherichia coli strains isolated from septicemic and healthy chickens in Spain, J. Clin. Microbiol., 35, 2184, 10.1128/jcm.35.8.2184-2185.1997

Blanco, 2004, Serotypes, virulence genes and intimin types of Shiga toxin (verotoxin)-producing Escherichia coli isolates from human patients: Prevalence in Lugo (Spain) from 1992 through 1999, J. Clin. Microbiol., 42, 311, 10.1128/JCM.42.1.311-319.2004

Blanco, 1993, Resistencia a antibióticos en Escherichia coli de origen bovino, Med. Vet., 10, 154

Blanco, 1993, Enterotoxigenic, verotoxigenic, and necrotoxigenic Escherichia coli isolated from cattle in Spain, Am. J. Vet. Res., 54, 1446, 10.2460/ajvr.1993.54.09.1446

Blanco, 1996, Prevalence and characteristics of Escherichia coli serotype O157:H7 and other verotoxin-producing E. coli in healthy cattle, Epidemiol. Infect., 117, 251, 10.1017/S0950268800001424

Blanco, 1997, Distribution and characterization of fecal verotoxin-producing Escherichia coli (VTEC) isolated from healthy cattle, Vet. Microbiol., 54, 309, 10.1016/S0378-1135(96)01292-8

Blanco, 2003, Serotypes, virulence genes, and intimin types of Shiga toxin (verotoxin)-producing Escherichia coli isolates from healthy sheep in Spain, J. Clin. Microbiol., 41, 1351, 10.1128/JCM.41.4.1351-1356.2003

Blanco, 2004, Serotypes, virulence genes and intimin types of Shiga toxin (verotoxin)-producing Escherichia coli isolates from cattle in Spain: Identification of a new intimin variant gene (eae-ɛ), J. Clin. Microbiol., 42, 645, 10.1128/JCM.42.2.645-651.2004

Bopp, 1987, Unusual verotoxin-producing Escherichia coli associated with hemorrhagic colitis, J. Clin. Microbiol., 25, 1486, 10.1128/jcm.25.8.1486-1489.1987

Cid, 1996, In vitro susceptibility of Escherichia coli strains isolated from diarrheic lambs and goat kids to 14 antimicrobial agents, J. Vet. Pharmacol. Therap., 19, 397, 10.1111/j.1365-2885.1996.tb00070.x

Desmarchelier, 1998, A PCR specific for Escherichia coli O157 based on the rfb locus encoding O157 lipopolysaccharide, J. Clin. Microbiol., 36, 1801, 10.1128/JCM.36.6.1801-1804.1998

Eklund, 2001, Clinical isolates of non-O157 Shiga toxin-producing Escherichia coli: Serotypes, virulence characteristics, and molecular profiles of strains of the same serotype, J. Clin. Microbiol., 39, 2829, 10.1128/JCM.39.8.2829-2834.2001

Farina, 1996, Antimicrobial susceptibility of Escherichia coli O157 and other enterohemorrhagic Escherichia coli isolated in Italy, Eur. J. Clin. Microbiol. Infect. Dis., 15, 351, 10.1007/BF01695674

Fukushima, 1999, Clinical experiences in Sakai City Hospital during the massive outbreak of enterohemorrhagic Escherichia coli O157 infections in Sakai City, 1996, Pediatr. Int., 41, 213, 10.1046/j.1442-200X.1999.4121041.x

Galland, 2001, Prevalence, antibiotic susceptibility, and diversity of Escherichia coli O157:H7 isolates from a longitudinal study of beef cattle feedlots, Appl. Environ. Microbiol., 67, 1619, 10.1128/AEM.67.4.1619-1627.2001

Gannon, 1997, Use of the flagellar H7 gene as a target in multiplex PCR assays and improved specificity in identification of enterohemorrhagic Escherichia coli strains, J. Clin. Microbiol., 35, 656, 10.1128/jcm.35.3.656-662.1997

González, 1989, Serotypes and antibiotic resistance of verotoxigenic (STEC) and necrotizing (NTEC) Escherichia coli strains isolated from calves with diarrhea, FEMS Microbiol. Lett., 60, 31, 10.1111/j.1574-6968.1989.tb03414.x

Griffin, 1991, The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic–uremic syndrome, Epidemiol. Rev., 13, 60, 10.1093/oxfordjournals.epirev.a036079

Griffin, 1995, Escherichia coli O157:H7 and other enterohemorrhagic Escherichia coli, 739

Guinée, 1981, Escherichia coli associated with neonatal diarrhea in piglets and calves, Curr. Top. Vet. Anim. Sci., 13, 126

Hiruta, 2001, An outbreak of diarrhea due to multiple antimicrobial-resistant Shiga toxin-producing Escherichia coli O26:H11 in a nursery, Epidemiol. Infect., 127, 221, 10.1017/S0950268801006069

Horii, 1998, Heterogeneity of phenotypic and genotypic traits including organic-acid resistance in Escherichia coli O157 isolates, Microbiol. Immunol., 42, 871, 10.1111/j.1348-0421.1998.tb02363.x

Ikeda, 1999, Effect of early fosfomycin treatment on prevention of hemolytic–uremic syndrome accompanying Escherichia coli O157:H7 infection, Clin. Nephrol., 52, 357

Izumikawa, 1998, Analysis of genetic relationships and antimicrobial susceptibility of verotoxin-producing Escherichia coli strains isolated in Nagasaki prefecture, Japan in 1996, Microbiol. Immunol., 42, 677, 10.1111/j.1348-0421.1998.tb02339.x

Jorgensen, 1999, Antibacterial susceptibility tests: Dilution and disk diffusion methods, 1526

Kaper, 1998, Attaching and effacing intestinal histopathology and the locus of enterocyte effacement, 163

Karmali, 1989, Infection by verocytotoxin-producing Escherichia coli, Clin. Microbiol. Rev., 2, 5, 10.1128/CMR.2.1.15

Khachatryan, 2004, Role of calf-adapted Escherichia coli in maintenance of antimicrobial drug resistance in dairy calves, Appl. Environ. Microbiol., 70, 752, 10.1128/AEM.70.2.752-757.2004

Khakria, 1990, Extended phage-typing scheme for Escherichia coli O157:H7, Epidemiol. Infect., 105, 511, 10.1017/S0950268800048135

Khan, 2002, Antibiotic ressistance, virulence gene, and molecular profiles of Shiga toxin-producing Escherichia coli isolates from diverse sources in Calcutta, India, J. Clin. Microbiol., 40, 2009, 10.1128/JCM.40.6.2009-2015.2002

Kim, 1994, Characteristics of antibiotic-resistant Escherichia coli O157:H7 in Washington state, 1984–1991, J. Infect. Dis., 70, 1606, 10.1093/infdis/170.6.1606

Kobayashi, 2001, Prevalence and characteristics of Shiga toxin-producing Escherichia coli from healthy cattle in Japan, Appl. Environ. Microbiol., 67, 484, 10.1128/AEM.67.1.484-489.2001

Maidhof, 2002, A multiresistant clone of Shiga toxin-producing Escherichia coli O118:H16 is spread in cattle and humans over different European countries, Appl. Environ. Microbiol., 68, 5834, 10.1128/AEM.68.12.5834-5842.2002

Meng, 1998, Antibiotic resistance of Escherichia coli O157:H7 and O157:NM isolated from animals, food, and humans, J. Food Prot., 1, 1511, 10.4315/0362-028X-61.11.1511

Mora, 2004, Phage types and genotypes of human and animal Shiga toxin-producing Escherichia coli O157:H7 in Spain. Identification of two predominating phage types (PT2 and PT8), J. Clin. Microbiol., 42, 4007, 10.1128/JCM.42.9.4007-4015.2004

National Committee for Clinical Laboratory Standards, Performance Standards for Antimicrobial Disk Susceptibility Tests, seventh ed., Approved Standard M2-A7. Committee for Clinical Laboratory Standards, Wayne, PA, 2000

Pai, 1984, Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7, Ann. Intern. Med., 101, 738, 10.7326/0003-4819-101-6-738

Paton, 1998, Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections, Clin. Microbiol. Rev., 11, 450, 10.1128/CMR.11.3.450

Pestana de Castro, 2003, Multidrug-resitant Shiga toxin-producing Escherichia coli O118:H16 in Latin America, Emerg. Infect. Dis., 9, 1027, 10.3201/eid0908.030062

Ratnam, 1988, Characterization of Escherichia coli serotype O157:H7, J. Clin. Microbiol., 26, 2006, 10.1128/jcm.26.10.2006-2012.1988

Remis, 1984, Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7, Ann. Intern. Med., 101, 624, 10.7326/0003-4819-101-5-624

Sáenz, 2001, Antibiotic resistance in Escherichia coli isolates obtained from animals, foods and humans in Spain, Int. J. Antimicrob. Agents, 18, 353, 10.1016/S0924-8579(01)00422-8

Schmidt, 1998, Antibiotic susceptibilities of verocytotoxin-producing Escherichia coli O157 and non-O157 strains isolated from patients and healthy subjects in Germany during 1996, J. Antimicrob. Chemother., 42, 548, 10.1093/jac/42.4.548

Schroeder, 2002, Antimicrobial resistance of Escherichia coli O26, O103, O111, O128, and O145 from animals and humans, Emerg. Infect. Dis., 8, 1409, 10.3201/eid0812.0200770

Schroeder, 2002, Antimicrobial resistance of Escherichia coli O157 isolated from humans, cattle, swine, and food, Appl. Environ. Microbiol., 68, 576, 10.1128/AEM.68.2.576-581.2002

Stephan, 2001, Resistance patterns of non-O157 Shiga toxin-producing Escherichia coli (STEC) strains isolated from animals, food and asymptomatic human carriers in Switzerland, Lett. Appl. Microbiol., 32, 114, 10.1046/j.1472-765x.2001.00867.x

Tarr, 1988, Escherichia coli O157:H7 hemorrhagic colitis (letter), New Engl. J. Med., 318, 1697, 10.1056/NEJM198806233182515

Teshager, 2000, Surveillance of antimicrobial resistance in Escherichia coli strains isolated from pigs at Spanish slaughterhouses, Int. J. Antimicrob. Agents, 15, 137, 10.1016/S0924-8579(00)00153-9

Thomas, 1996, Verocytotoxin-producing Escherichia coli, particularly serogroup O157 associated with human infections in England and Wales: 1992–1994, Epidemiol. Infect., 117, 1, 10.1017/S0950268800001060

Walterspiel, 1992, Effect of subinhibitory concentrations of antibiotics on extracellular Shiga-like toxin 1, Infection., 20, 25, 10.1007/BF01704889

White, 2002, Characterization of antimicrobial resistance among Escherichia coli O111 isolates of animal and human origin, Microb. Drug Resist., 8, 139, 10.1089/107662902760190699

Willshaw, 2001, Verocytotoxin-producing Escherichia coli (VTEC) O157 and other VTEC from human infections in England and Wales: 1995–1998, J. Med. Microbiol., 50, 135, 10.1099/0022-1317-50-2-135

Witte, 1998, Medical consequences of antibiotic use in agriculture, Science, 279, 996, 10.1126/science.279.5353.996

Wong, 2000, The risk of hemolytic–uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections, New Engl. J. Med., 342, 1930, 10.1056/NEJM200006293422601

Yamamoto, 1998, Status of emerging drug resistance in Shiga toxin-producing Escherichia coli in Japan during 1996: A minireview, Nippon Rinsho., 56, 2718

Zhang, 2000, Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice, J. Infect. Dis., 181, 664, 10.1086/315239

Zhao, 2001, Identification and characterization of integron-mediated antibiotic resistance among Shiga toxin-producing Escherichia coli isolates, Appl. Environ. Microbiol., 67, 1558, 10.1128/AEM.67.4.1558-1564.2001

M. Braoudaki, A.C. Hilton, 5th Int. Symp. Shiga toxin (verocytotoxin)-producing Escherichia coli infections, Edinburgh, UK, abstract P99, p. 128, 2003

B. Jiggle, T. Cheasty, G. Willshaw, 5th Int. Symp. Shiga Toxin (Verocytotoxin)-Producing Escherichia coli Infections, Edinburgh, UK, abstract P241, p. 201, 2003